Carotid intima-media thickness in patients with liver cirrhosis associated with diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 78, Issue 2, 2007, Pages 176-181

  Tamura, Miho ^a   Kihara, Yasuyuki ^a   Otsuki, Makoto ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Atherosclerosis; Diabetes mellitus; Liver cirrhosis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTERIAL PRESSURE; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY; CLINICAL ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIVER CIRRHOSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; THICKNESS; THROMBOCYTE COUNT;

AGED; ATHEROSCLEROSIS; CAROTID ARTERY, COMMON; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 34648847042     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.03.013     Document Type: Article

References (40)

1. Pignoli P., Tremoli E., Poli A., Oreste P., and Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74 (1986) 1399-1406
2. Handa N., Matsumoto M., Maeda H., Hougaku H., Ogawa S., Fukunaga R., et al. Ultrasonic evaluation early carotid atherosclerosis. Stroke 21 (1990) 1567-1572
3. Kawamori R., Yamasaki Y., Matsushima H., Nishizawa H., Nao K., Hougaku H., et al. Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 15 (1992) 1290-1294
4. Braunwald E. Shattuck Lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med. 337 (1997) 1360-1369
5. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
6. Kannel W.B. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 40 (2005) 1215-1220
7. The Diabetes Prevention Program Research Group: Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program. Diabetes Care 28 (2005) 2472-2479.
8. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
9. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17 (2006) 4-12
10. Kuter D.J., Beeler D.L., and Rosemberg R.D. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11104-11108
11. Stoffel R., Wiestner A., and Skoda R.C. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87 (1996) 567-573
12. Megyesi C., Samols E., and Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 290 (1967) 1051-1056
13. Petrides A.S., and DeFronzo R.A. Glucose and insulin metabolism in cirrhosis. J. Hepatol. 8 (1989) 107-114
14. Loyke H.F. The relationship of cirrhosis of the liver to hypertension: a study of 504 cases of cirrhosis of the liver. Am. J. Med. Sci. 230 (1955) 627-632
15. Marchesini G., Ronchi M., Forlani G., Bugianesi E., Bianchi G., Fabbri A., et al. Cardiovascular disease in cirrhosis-a point-prevalence study in relation to glucose tolerance. Am. J. Gastroenterol. 94 (1999) 655-662
16. Kuzuya T., Nakagawa S., Satoh J., Kanazawa Y., Iwamoto Y., Kobayashi M., et al. Report of the committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus. J. Jpn. Diab Soc. 42 (1999) 385-404 (in Japanese)
17. Tremblay A.J., Morrissette H., Gagne J.M., Bergeron J., Gagne C., and Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin. Biochem. 37 (2004) 785-790
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
19. Arnett D.K., Tyroler H.A., Burke G., Hutchinson R., Howard G., and Heiss G. Hypertension and subclinical carotid artery atherosclerosis in blacks and whites. The Atherosclerosis Risk in Communities Study. ARIC Investigators. Arch. Intern Med. 156 (1996) 1983-1989
20. Ebrahim S., Papacosta O., Whincup P., Wannamethee G., Walker M., Nicolaides A.N., et al. Carotid plaque, intima media thickness, cardiovascular disease in men and women: the British regional heart study. Stroke 30 (1999) 841-850
21. Howard G., Burke G.L., Szklo M., Tell G.S., Eckfeldt J., Evans G., et al. Active and passive smoking are associated with increased carotid wall thickness. The atherosclerosis risk in communities study. Arch. Intern Med. 154 (1994) 1277-1282
22. Brohall G., Oden A., and Fagerberg B. Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet. Med. 23 (2006) 609-616
23. Holstein A., Hinze S., Thiessen E., Plaschke A., and Egberts E.H. Clinical implications of hepatogenous diabetes in liver cirrhosis. J. Gastroenterol. Hepatol. 17 (2002) 677-681
24. Cleed D.L., Braird W.F., and Fisher E.R. The severity of aortic arteriosclerosis in certain diseases: a necropsy study. Am. J. Med. Sci. 230 (1955) 385-391
25. Marchesini G., Ronchi M., Forlani G., Bugianesi E., Bianchi G., Fabbri A., et al. Cardiovascular disease in cirrhosis-a point-prevalence study in relation to glucose tolerance. Am. J. Gastroenterol. 94 (1999) 655-662
26. Allocca M., Crosignani A., Gritti A., Ghilardi G., Gobatti D., Caruso D., et al. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut 55 (2006) 1795-1800
27. Imano E., Kanda T., Nakatani Y., Motomura M., Arai K., Matsuhisa M., et al. Impaired splanchnic and peripheral glucose uptake in liver cirrhosis. J. Hepatol. 31 (1999) 469-473
28. Cavallo-Perin P., Cassader M., Bozzo C., Bruno A., Nuccio P., Dall'Omo A.M., et al. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J. Clin. Invest 75 (1985) 1659-1665
29. Kanda T., Nakamura M., Iwasaki M., Wada M., Kurotobi M., and Shimizu Y. Clinical significance of HbA1c, serum fructosamine and 1,5-AG in diabetic patients complicated with liver cirrhosis. J. Jpn. Diab. Soc. 36 (1993) 847-854 (in Japanese with English abstract)
30. DECODE Study Group, Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. The DECODE study. Lancet 354 (1999) 617-621.
31. DECODE Study Group, Glucose tolerance and cardiovascular mortality: comparison of the fasting and the 2-h diagnostic criteria. Arch Intern Med 161 (2001) 397-404.
32. Gao W., Qiao Q., and Tuomilehto J. Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events. Clin. Lab. 50 (2004) 609-615
33. Hanefeld M., Fischer S., Julius U., Schulze J., Schwanebeck U., Schmechel H., et al. Risk factors for myocardial infarction and death in newly detected NIDDM: The diabetes intervention study. 11-year follow-up. Diabetologia 39 (1996) 1577-1583
34. Maresca G., Di Blasio A., Marchioli R., and Di Minno G. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an uptake. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1368-1377
35. Sato S., Nakamura M., Iida M., Naito Y., Kitamura A., Okamura T., et al. Plasma fibrinogen and coronary heart disease in urban Japanese. Am. J. Epidemiol. 152 (2000) 420-423
36. Kawamori R., Imano E., Watarai T., Nishizawa H., Matsushima H., Kodama M., et al. Platelet activation in diabetic patients with asymptomatic atherosclerosis. Diabetes Res. Clin. Pract. 24 (1994) 89-95
37. Massberg S., Brand K., Gruner S., Page S., Muller E., Muller I., et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196 (2002) 887-896
38. Burger P.C., and Wagner D.D. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101 (2003) 2661-2666
39. Tschoepe D., Roesen P., Esser J., Schwippert B., Nieuwenhuis H.K., Kehrel B., et al. Large platelets circulate in an activated state in diabetes mellitus. Semin. Thromb. Hemost. 17 (1991) 433-438
40. Giannini E., Botta F., Borro P., Malfatti F., Fumagalli A., Testa E., et al. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am. J. Gastroenterol. 98 (2003) 2516-2520